Prenetics Global Ltd Überblick
Branche: Biotechnology & Medical Research
Sektor: Healthcare
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong. Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-ca
Research-Überblick
Letztes Berichtsdatum 2026-08-26Diese Mavefund-Research-Seite bündelt geprüfte Informationen zu Prenetics Global Ltd (PRE): Unternehmensprofil, Kursverlauf, verknüpfte Primärquellen, verfügbare Finanzberichte, Research-Signale und zu prüfende Risiken.
- Börsennotierung
- PRE · Nasdaq · MIC XNAS
- Land
- United States
- Handelswährung
- USD
- Branche
- Biotechnology & Medical Research
- Finanzdaten
- Jahres- und Zwischenabschlüsse verfügbar
- Letzte Primärquelle
- SEC EDGAR · veröffentlicht 2026-08-26
Primärquellen
- Letzter Bericht · SEC EDGAR Veröffentlicht 2026-08-26
- Registrierungsdokument
Die Abdeckung wird automatisch aktualisiert und erst nach einer Datenintegritätsprüfung veröffentlicht. Nur Research-Unterstützung; keine persönliche Anlageberatung.
Mavefund ordnet die verfügbaren Fundamentaldaten, Bewertungskennzahlen und Risikofaktoren von Prenetics Global Ltd für einen nachvollziehbaren Research-Prozess ein.
Score
Veröffentlichte Ergebnisse
Was das Unternehmen berichtet hat – mit kompakter Quellenangabe.
Interim result summary
Revenue was $46.5M (reported).
Revenue
$46.5M
reported
Was sich verändert hat
- Revenue reported to $46.5M.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.
Earnings release
Bericht öffnen
Source: SEC EDGAR company-filed earnings materials. Dates and source identifiers are retained for verification; review the original filing before relying on extracted report details.
Weitere aktuelle Ergebnisunterlagen
SEC filing
6-K
Aug 26, 2026
SEC filing
6-K
Aug 20, 2026
SEC filing
6-K
Aug 18, 2026
Earnings release
Earnings release
Aug 18, 2026
SEC filing
EX-99.2
Aug 18, 2026
Earnings material
Earnings release
Aug 18, 2026
SEC filing
6-K
Aug 17, 2026
Earnings release
Earnings release
Aug 17, 2026
SEC filing
6-K
Aug 07, 2026
Earnings release
Earnings release
Aug 07, 2026
SEC filing
20-F/A
Jul 30, 2026
Geprüfte Signal-Evidenz
Aktuelle Nachrichten
Unternehmensrelevante Artikel aus Quellen, die die Relevanz- und Zuverlässigkeitsprüfung des Mave Signals bestehen.
Equity Futures Mixed Pre-Bell Ahead of Key Inflation Report, Nvidia Earnings
Headline from Yahoo Finance: Equity Futures Mixed Pre-Bell Ahead of Key Inflation Report, Nvidia Earnings.
Zoom Communications Third-Quarter Earnings Outlook Misses Street Views; Shares Down Pre-Bell
Headline from Yahoo Finance: Zoom Communications Third-Quarter Earnings Outlook Misses Street Views; Shares Down Pre-Bell.
Cambrex High Point Completes FDA, PMDA and TGA Pre-Approval Inspections, Advancing Commercial Manufacturing Capabilities
Headline from PR Newswire: Cambrex High Point Completes FDA, PMDA and TGA Pre-Approval Inspections, Advancing Commercial Manufacturing Capabilities.
Stocks Down Pre-Bell as Investors Await Key Inflation Data, Warsh Speech, Nvidia Earnings
Headline from Yahoo Finance: Stocks Down Pre-Bell as Investors Await Key Inflation Data, Warsh Speech, Nvidia Earnings.
Put Traders Target Retailer Amid Pre-Earnings Pullback
Headline from Yahoo Finance: Put Traders Target Retailer Amid Pre-Earnings Pullback.
Prenetics Global Limited Q2 2026 Earnings Call Summary
Headline from Yahoo Finance: Prenetics Global Limited Q2 2026 Earnings Call Summary.
Gewinn je Aktie
Score 3.00/5
Prenetics Global Ltd boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
In
Biotechnology & Medical Research industry
, Syneos Health
, Pluri Inc
, PureTech Health PLC
are companies with high ratings.
Eigenkapitalrendite
Score 1.96/5
Prenetics Global Ltd exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
Eigenkapitalrendite
Unternehmen —
Sektormedian —
0%
10%
20%
30%
40%
Eigenkapitalrendite
Unternehmen —
Sektormedian —
0%
10%
20%
30%
40%
Eigenkapitalrendite
Unternehmen —
Sektormedian —
0%
10%
20%
30%
40%
Eigenkapitalrendite
Unternehmen —
Sektormedian —
Kennzahlen-Chart vorübergehend nicht verfügbar.
Nettomarge
Score 2.21/5
Prenetics Global Ltd
olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
Nettomarge
Unternehmen —
Sektormedian —
0%
10%
20%
30%
40%
Nettomarge
Unternehmen —
Sektormedian —
0%
10%
20%
30%
40%
Nettomarge
Unternehmen —
Sektormedian —
0%
10%
20%
30%
40%
Nettomarge
Unternehmen —
Sektormedian —
Kennzahlen-Chart vorübergehend nicht verfügbar.
Verschuldung
Score 3.26/5
Prenetics Global Ltd
attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
, also exhibit high scores.
0
1
2
3
4
Verschuldungsgrad
Unternehmen —
Sektormedian —
0
1
2
3
4
Verschuldungsgrad
Unternehmen —
Sektormedian —
0
1
2
3
4
Verschuldungsgrad
Unternehmen —
Sektormedian —
0
1
2
3
4
Verschuldungsgrad
Unternehmen —
Sektormedian —
Kennzahlen-Chart vorübergehend nicht verfügbar.
Finanzberichte
Vom Unternehmen veröffentlichte Berichtsdaten, strukturiert und mit der Originalquelle verknüpft.
Geprüfte, quellenverknüpfte Finanzberichte werden geladen, sobald dieser Abschnitt sichtbar wird.
Quellendetails werden mit den Berichtsdaten geladen. Die Werte sind standardisierte Unternehmensangaben zur Research-Unterstützung, keine persönliche Anlageberatung.
Finanzkennzahlen
Jährlich
Quartalsweise
Finanzen
Profitabilität
Wachstum
Cashflow
Finanzielle Stabilität
Effizienzkennzahlen